<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1479" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1479/" /><meta name="ncbi_pagename" content="Sotos Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Sotos Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Sotos Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/08/01" /><meta name="citation_author" content="Katrina Tatton-Brown" /><meta name="citation_author" content="Trevor RP Cole" /><meta name="citation_author" content="Nazneen Rahman" /><meta name="citation_pmid" content="20301652" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1479/" /><meta name="citation_keywords" content="Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific" /><meta name="citation_keywords" content="NSD1" /><meta name="citation_keywords" content="Sotos Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Sotos Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Katrina Tatton-Brown" /><meta name="DC.Contributor" content="Trevor RP Cole" /><meta name="DC.Contributor" content="Nazneen Rahman" /><meta name="DC.Date" content="2019/08/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1479/" /><meta name="description" content="Sotos syndrome is characterized by a distinctive facial appearance (broad and prominent forehead with a dolichocephalic head shape, sparse frontotemporal hair, downslanting palpebral fissures, malar flushing, long and narrow face, long chin); learning disability (early developmental delay, mild-to-severe intellectual impairment); and overgrowth (height and/or head circumference ≥2 SD above the mean). These three clinical features are considered the cardinal features of Sotos syndrome. Major features of Sotos syndrome include behavioral problems (most notably autistic spectrum disorder), advanced bone age, cardiac anomalies, cranial MRI/CT abnormalities, joint hyperlaxity with or without pes planus, maternal preeclampsia, neonatal complications, renal anomalies, scoliosis, and seizures." /><meta name="og:title" content="Sotos Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Sotos syndrome is characterized by a distinctive facial appearance (broad and prominent forehead with a dolichocephalic head shape, sparse frontotemporal hair, downslanting palpebral fissures, malar flushing, long and narrow face, long chin); learning disability (early developmental delay, mild-to-severe intellectual impairment); and overgrowth (height and/or head circumference ≥2 SD above the mean). These three clinical features are considered the cardinal features of Sotos syndrome. Major features of Sotos syndrome include behavioral problems (most notably autistic spectrum disorder), advanced bone age, cardiac anomalies, cranial MRI/CT abnormalities, joint hyperlaxity with or without pes planus, maternal preeclampsia, neonatal complications, renal anomalies, scoliosis, and seizures." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1479/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sotos/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1479/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A40B7E04091C10000000001A6009B.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1479_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1479_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/snyder-robinson/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/spg3a/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1479_"><span class="title" itemprop="name">Sotos Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Katrina Tatton-Brown</span>, BM BCh, MD, <span itemprop="author">Trevor RP Cole</span>, MB ChB, and <span itemprop="author">Nazneen Rahman</span>, BM BCh, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1479_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1479_ai__"><div class="contrib half_rhythm"><span itemprop="author">Katrina Tatton-Brown</span>, BM BCh, MD<div class="affiliation small">Consultant in Clinical Genetics, South West Thames Regional Genetics Service<br />Professor in Clinical Genetics and Genomic Education<br />St George&#x02019;s University of London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lugs@nottatk" class="oemail">ku.ca.lugs@nottatk</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Trevor RP Cole</span>, MB ChB<div class="affiliation small">Consultant and Honorary Reader in Clinical Genetics, Clinical Genetics Unit<br />Birmingham Women&#x02019;s Hospital<br />Birmingham, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.shneht.snemow-mahb@eloc.rovert" class="oemail">moc.shneht.snemow-mahb@eloc.rovert</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Nazneen Rahman</span>, BM BCh, PhD<div class="affiliation small">Professor and Honorary Consultant in Medical Genetics, Cancer Genetics Section<br />Institute of Cancer Research<br />Sutton, Surrey, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.rci@namhar.neenzan" class="oemail">ku.ca.rci@namhar.neenzan</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 17, 2004</span>; Last Update: <span itemprop="dateModified">August 1, 2019</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sotos.Summary" itemprop="description"><h2 id="_sotos_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Sotos syndrome is characterized by a distinctive facial appearance (broad and prominent forehead with a dolichocephalic head shape, sparse frontotemporal hair, downslanting palpebral fissures, malar flushing, long and narrow face, long chin); learning disability (early developmental delay, mild-to-severe intellectual impairment); and overgrowth (height and/or head circumference &#x02265;2 SD above the mean). These three clinical features are considered the cardinal features of Sotos syndrome. Major features of Sotos syndrome include behavioral problems (most notably autistic spectrum disorder), advanced bone age, cardiac anomalies, cranial MRI/CT abnormalities, joint hyperlaxity with or without <i>pes planus</i>, maternal preeclampsia, neonatal complications, renal anomalies, scoliosis, and seizures.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Sotos syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> encompassing <i>NSD1</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Referral to appropriate specialists for management of learning disability / speech delays, behavior problems, cardiac abnormalities, renal anomalies, scoliosis, seizures; intervention is not recommended if the brain MRI shows ventricular dilatation without raised intracranial pressure.</p><p><i>Surveillance:</i> Regular review by a general pediatrician for younger children, individuals with many medical complications, and families requiring more support than average; less frequent review of older children / teenagers and those individuals without many medical complications.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Sotos syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. More than 95% of individuals have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. If neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has Sotos syndrome, the risk to sibs of the proband is low (&#x0003c;1%). The risk to offspring of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is 50%. Prenatal testing for pregnancies at risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the <i>NSD1</i> pathogenic variant has been identified in an affected family member.</p></div></div><div id="sotos.Diagnosis"><h2 id="_sotos_Diagnosis_">Diagnosis</h2><div id="sotos.Suggestive_Findings"><h3>Suggestive Findings</h3><p>No formal clinical diagnostic criteria are published for Sotos syndrome; the clinical diagnosis <b>should be suspected</b> in individuals with the following features.</p><p><b>Characteristic facial appearance</b> (most easily recognizable between ages 1 and 6 years):</p><ul><li class="half_rhythm"><div class="half_rhythm">Broad, prominent forehead with a dolichocephalic head shape</div></li><li class="half_rhythm"><div class="half_rhythm">Sparse frontotemporal hair</div></li><li class="half_rhythm"><div class="half_rhythm">Downslanting palpebral fissures</div></li><li class="half_rhythm"><div class="half_rhythm">Malar flushing</div></li><li class="half_rhythm"><div class="half_rhythm">Long narrow face (particularly bitemporal narrowing)</div></li><li class="half_rhythm"><div class="half_rhythm">Long chin</div><div class="half_rhythm">Note: Facial shape is retained into adulthood; with time the chin becomes broader (squarer in shape).</div></li></ul><p><b>Learning disability</b></p><ul><li class="half_rhythm"><div>Early developmental delay</div></li><li class="half_rhythm"><div>Mild-to-severe intellectual impairment</div></li></ul><p><b>Overgrowth</b></p><ul><li class="half_rhythm"><div>Height and/or head circumference &#x02265;2 SD above the mean (i.e., ~98th centile)</div><div>Note: Height may normalize in adulthood.</div></li><li class="half_rhythm"><div>Macrocephaly usually present at all ages</div></li></ul><p>Note: Based on the analysis of more than 266 individuals with an <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the three cardinal features (facial appearance, learning disability, and overgrowth) were shown to occur in at least 90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>].</p></div><div id="sotos.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Sotos syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>NSD1</i> or a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> encompassing <i>NSD1</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1479/table/sotos.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figsotosTmoleculargenetictestingusedi" rid-ob="figobsotosTmoleculargenetictestingusedi">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing and <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis, <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Sotos syndrome is broad, individuals with the distinctive findings described in <a href="#sotos.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#sotos.Option_1">Option 1</a>), whereas those with atypical features in whom the diagnosis of Sotos syndrome has not been considered are more likely to be diagnosed using genomic testing (see <a href="#sotos.Option_2">Option 2</a>).</p><div id="sotos.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of Sotos syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>NSD1</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div><div class="half_rhythm"><b>Note: Chromosomal microarray analysis (CMA)</b> uses oligonucleotide or SNP arrays to detect genome-wide large deletions/duplications (including <i>NSD1</i>) that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. Many individuals with developmental delay will have had CMA as part of their evaluation, sometimes prior to the consideration of Sotos syndrome as a possibility. CMA designs in current clinical use target the <i>NSD1</i> region. Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> assays may have higher resolution than CMA; however, testing is unlikely to detect a deletion or duplication in cases where sequence analysis and CMA of <i>NSD1</i> was not diagnostic.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>NSD1</i> and other genes of interest (see <a href="#sotos.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For this disorder a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that also includes <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is recommended (see <a class="figpopup" href="/books/NBK1479/table/sotos.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figsotosTmoleculargenetictestingusedi" rid-ob="figobsotosTmoleculargenetictestingusedi">Table 1</a>).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul></div><div id="sotos.Option_2"><h4>Option 2</h4><p>When the diagnosis of Sotos syndrome is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is the most commonly used genomic testing method; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="sotos.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Sotos Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1479/table/sotos.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sotos.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sotos.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_sotos.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_sotos.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_sotos.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>NSD1</i></td><td headers="hd_h_sotos.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_sotos.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">45%-80%</td></tr><tr><td headers="hd_h_sotos.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>4</sup></td><td headers="hd_h_sotos.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%-50%&#x000a0;<sup>5,&#x000a0;6</sup></td></tr><tr><td headers="hd_h_sotos.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>7</sup></td><td headers="hd_h_sotos.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20%-55%&#x000a0;<sup>7</sup><sup>,</sup>&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sotos.TF.1.1"><p class="no_margin">See <a href="/books/NBK1479/#sotos.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="sotos.TF.1.2"><p class="no_margin">See <a href="#sotos.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="sotos.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="sotos.TF.1.4"><p class="no_margin">Chromosomal microarray analysis (CMA) uses oligonucleotide or SNP arrays to detect genome-wide large deletions/duplications (including <i>NSD1</i>) that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. The ability to determine the size of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> depends on the type of microarray used and the density of probes in the 5q35 region. Typically, single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications are below the resolution of CMA detection. CMA designs in current clinical use target the 5q35 region and <i>NSD1</i>.</p></div></dd><dt>5. </dt><dd><div id="sotos.TF.1.5"><p class="no_margin">ClinGen-<a href="https://www.ncbi.nlm.nih.gov/projects/dbvar/clingen/clingen_region.cgi?id=ISCA-37425" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ISCA-37425</a>. Standardized clinical annotation and interpretation for <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> variants from the <a href="http://www.clinicalgenome.org/about/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Clinical Genome Resource (ClinGen) project</a> (formerly the International Standards for Cytogenomic Arrays [ISCA] Consortium).</p></div></dd><dt>6. </dt><dd><div id="sotos.TF.1.6"><p class="no_margin">The incidence of the common 1.9-Mb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> varies by population [<a class="bk_pop" href="#sotos.REF.kurotaki.2003.378">Kurotaki et al 2003</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2005a.307">Tatton-Brown et al 2005a</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>, <a class="bk_pop" href="#sotos.REF.visser.2005.e66">Visser et al 2005</a>].</p></div></dd><dt>7. </dt><dd><div id="sotos.TF.1.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications. Gene-targeted deletion/duplication testing will detect deletions ranging from a single exon to the whole gene; however, breakpoints of large deletions and/or deletion of adjacent genes (e.g., the 1.9-Mb deletion) may not be detected by these methods.</p></div></dd><dt>8. </dt><dd><div id="sotos.TF.1.8"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> may detect an additional 1%-5% of partial-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions.</p></div></dd></dl></div></div></div></div></div></div><div id="sotos.Clinical_Characteristics"><h2 id="_sotos_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sotos.Clinical_Description"><h3>Clinical Description</h3><p>Based on a review of 266 persons with <i>NSD1</i> abnormalities, the clinical features of Sotos syndrome were classified as cardinal features (occurring in &#x02265;90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals), major features (occurring in 15%-89%), and associated features (occurring in &#x02265;2% and &#x0003c;15% of persons) [<a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>].</p><p><a href="#sotos.Cardinal_Features"><b>Cardinal features</b></a> (present in &#x02265;90% of persons with Sotos syndrome)</p><ul><li class="half_rhythm"><div>Characteristic facial appearance</div></li><li class="half_rhythm"><div>Learning disability</div></li><li class="half_rhythm"><div>Overgrowth (height and/or head circumference &#x02265;2 SD above mean)</div></li></ul><p><a href="#sotos.Major_Features"><b>Major features</b></a> (present in 15%-89% of persons with Sotos syndrome)</p><ul><li class="half_rhythm"><div>Behavioral problems &#x02013; most notably autistic spectrum disorder</div></li><li class="half_rhythm"><div>Advanced bone age</div></li><li class="half_rhythm"><div>Cardiac anomalies</div></li><li class="half_rhythm"><div>Cranial MRI/CT abnormalities</div></li><li class="half_rhythm"><div>Joint hyperlaxity with or without <i>pes planus</i></div></li><li class="half_rhythm"><div>Maternal preeclampsia</div></li><li class="half_rhythm"><div>Neonatal complications</div></li><li class="half_rhythm"><div>Renal anomalies</div></li><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Seizures</div></li></ul><div id="sotos.Cardinal_Features"><h4>Cardinal Features</h4><p><b>Characteristic facial appearance.</b> The facial gestalt is the most specific diagnostic criterion for Sotos syndrome, and also the one most open to observer error due to inexperience. The facial gestalt of Sotos syndrome is evident at birth, but becomes most recognizable between ages one and six years. The head is dolichocephalic and the forehead broad and prominent. Often the hair in the frontotemporal region is sparse. The palpebral fissures are usually downslanting. Malar flushing may be present. In childhood the jaw is narrow with a long chin; in adulthood the chin broadens [<a class="bk_pop" href="#sotos.REF.allanson.1996.13">Allanson &#x00026; Cole 1996</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2004.199">Tatton-Brown &#x00026; Rahman 2004</a>]. In older children and adults, the facial features, although still typical, can be more subtle [<a class="bk_pop" href="#sotos.REF.allanson.1996.13">Allanson &#x00026; Cole 1996</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>].</p><p><b>Learning disability.</b> Delay of early developmental milestones is very common and motor skills may appear particularly delayed because of a child's large size, hypotonia, and poor coordination. The majority of individuals with Sotos syndrome have some degree of intellectual impairment. The spectrum is broad and ranges from a mild learning disability (<a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals would be expected to live independently and have their own families) to a severe learning disability (affected individuals would be unlikely to live independently as adults). The level of intellectual impairment generally remains stable throughout life [<a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>, <a class="bk_pop" href="#sotos.REF.foster.2019">Foster et al 2019</a>]. The learning disability in children with Sotos syndrome is characterized by relative strength in verbal ability and visuospatial memory but relative weakness in nonverbal reasoning ability and quantitative reasoning [<a class="bk_pop" href="#sotos.REF.lane.2019.240">Lane et al 2019</a>].</p><p><b>Overgrowth.</b> Sotos syndrome is associated with overgrowth of prenatal onset. Delivery is typically at term. The average birth length approximates to the 98th centile and the average birth head circumference is between the 91st and 98th centiles. Average birth weight is within the normal range (50th-91st centile).</p><p>Before age ten years, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children often demonstrate rapid linear growth. They are often described as being considerably taller than their peers. Approximately 90% of children have a height and/or head circumference at least 2 SD above the mean [<a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>]. However, growth is also influenced by parental heights and some individuals do not have growth parameters above the 98th centile [<a class="bk_pop" href="#sotos.REF.cole.1994.20">Cole &#x00026; Hughes 1994</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>].</p><p>Height may normalize in adulthood, but macrocephaly is usually present at all ages [<a class="bk_pop" href="#sotos.REF.agwu.1999.339">Agwu et al 1999</a>, <a class="bk_pop" href="#sotos.REF.foster.2019">Foster et al 2019</a>]. Data on final adult height are scarce; however, in both men and women, the range of final adult height is broad [<a class="bk_pop" href="#sotos.REF.agwu.1999.339">Agwu et al 1999</a>, <a class="bk_pop" href="#sotos.REF.foster.2019">Foster et al 2019</a>].</p><p>The <a class="bk_pop" href="#sotos.REF.de_boer.2005.1142">de Boer et al [2005]</a> study of auxologic data supports that of <a class="bk_pop" href="#sotos.REF.agwu.1999.339">Agwu et al [1999]</a> and shows that individuals with an <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have an increased arm span / height ratio, decreased sitting/standing height ratio, and increased hand length. These data suggest that the increased height in Sotos syndrome is predominantly the result of an increase in limb length [<a class="bk_pop" href="#sotos.REF.agwu.1999.339">Agwu et al 1999</a>, <a class="bk_pop" href="#sotos.REF.de_boer.2005.1142">de Boer et al 2005</a>].</p></div><div id="sotos.Major_Features"><h4>Major Features</h4><p><b>Behavioral problems.</b> A wide range of behavioral problems are common at all ages: autistic spectrum disorder, phobias, and aggression have been described [<a class="bk_pop" href="#sotos.REF.sheth.2015.2945">Sheth et al 2015</a>; <a class="bk_pop" href="#sotos.REF.lane.2017.135">Lane et al 2017</a>; <a class="bk_pop" href="#sotos.REF.lane.2019.240">Lane et al 2019</a>; <a class="bk_pop" href="#sotos.REF.foster.2019">Foster et al 2019</a>; Tatton-Brown, personal communication]. Often difficulty with peer group relationships is precipitated by large size, naivet&#x000e9;, and lack of awareness of social cues [<a class="bk_pop" href="#sotos.REF.finegan.1994.1307">Finegan et al 1994</a>]. These observations were confirmed in a study of individuals with a clinical diagnosis of Sotos syndrome (some with and some without an <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>); it was additionally noted that attention-deficit/hyperactivity disorder is not common among individuals with Sotos syndrome [<a class="bk_pop" href="#sotos.REF.de_boer.2006.582">de Boer et al 2006</a>].</p><p><b>Advanced bone age.</b> Bone age often reflects the accelerated growth velocity and is advanced in 75%-80% of prepubertal children. However, bone age interpretation is influenced by the "threshold" taken as significant, the method of assessment, subjective interpretative error, and the age at which the assessment is made.</p><p><b>Cardiac anomalies.</b> About 20% of individuals have cardiac anomalies that range in severity from single, often self-limiting anomalies (including patent ductus arteriosus, atrial septal defect, and ventricular septal defect) to more severe, complex cardiac abnormalities. Two unrelated individuals with Sotos syndrome have been shown to have left ventricular non-compaction [<a class="bk_pop" href="#sotos.REF.martinez.2011.1115">Martinez et al 2011</a>]. Three adult patients with Sotos syndrome and aortic dilatation have been reported [<a class="bk_pop" href="#sotos.REF.hood.2016.531">Hood et al 2016</a>].</p><p><b>Cranial MRI/CT abnormalities</b> are identified in the majority of individuals with Sotos syndrome and an <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Ventricular dilatation (particularly in the trigone region) is most frequently identified; other abnormalities include midline changes (hypoplasia or agenesis of the corpus callosum, mega cisterna magna, cavum septum pellucidum), cerebral atrophy, and small cerebellar vermis [<a class="bk_pop" href="#sotos.REF.waggoner.2005.524">Waggoner et al 2005</a>].</p><p><b>Joint hyperlaxity / <i>pes planus</i>.</b> Joint laxity is reported in at least 20% of individuals with Sotos syndrome.</p><p><b>Maternal preeclampsia</b> occurs in about 15% of pregnancies of children with Sotos syndrome.</p><p><b>Neonatal complications.</b> Neonates may have jaundice (~65%), hypotonia (~75%), and poor feeding (~70%). These complications tend to resolve spontaneously, but in a small minority intervention is required.</p><p><b>Renal anomalies.</b> About 15% of individuals with an <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a renal anomaly; vesicoureteral reflux is the most common. Some individuals may have quiescent vesicoureteral reflux and may present in adulthood with renal impairment.</p><p><b>Scoliosis.</b> Present in about 30% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, scoliosis is rarely severe enough to require bracing or surgery.</p><p><b>Seizures.</b> Approximately 25% of individuals with Sotos syndrome develop non-febrile seizures at some point in their lives and some require ongoing therapy. Absence, tonic-clonic, myoclonic, and partial complex seizures have all been reported.</p></div><div id="sotos.Associated_Features"><h4>Associated Features</h4><p><b>Tumors</b> occur in approximately 3% of persons with Sotos syndrome. The broad range includes sacrococcygeal teratoma, neuroblastoma, presacral ganglioma, acute lymphoblastic leukemia, small-cell lung cancer, and astrocytoma [<a class="bk_pop" href="#sotos.REF.hersh.1992.572">Hersh et al 1992</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2004.199">Tatton-Brown &#x00026; Rahman 2004</a>, <a class="bk_pop" href="#sotos.REF.theodoulou.2015.413">Theodoulou et al 2015</a>]. De Boer and colleagues have characterized and reviewed these problems and compared persons with Sotos syndrome who have <i>NSD1</i> pathogenic variants to those who do not [<a class="bk_pop" href="#sotos.REF.de_boer.2006.582">de Boer et al 2006</a>].</p><p><b>Various other clinical features</b> have been associated with Sotos syndrome. Some associated features, such as constipation and hearing problems caused by chronic otitis media, are common. The following features are seen in &#x02265;2% and &#x0003c;15% of individuals with Sotos syndrome [<a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>]:</p><ul><li class="half_rhythm"><div>Astigmatism</div></li><li class="half_rhythm"><div>Cataract</div></li><li class="half_rhythm"><div>Cholesteatoma</div></li><li class="half_rhythm"><div>Conductive hearing loss</div></li><li class="half_rhythm"><div>Constipation</div></li><li class="half_rhythm"><div>Contractures</div></li><li class="half_rhythm"><div>Craniosynostosis</div></li><li class="half_rhythm"><div>Cryptorchidism</div></li><li class="half_rhythm"><div>Gastroesophageal reflux</div></li><li class="half_rhythm"><div>Hemangioma</div></li><li class="half_rhythm"><div>Hemihypertrophy</div></li><li class="half_rhythm"><div>Hirschsprung's disease</div></li><li class="half_rhythm"><div>Hydrocele</div></li><li class="half_rhythm"><div>Hypercalcemia</div></li><li class="half_rhythm"><div>Hypermetropia</div></li><li class="half_rhythm"><div>Hypodontia</div></li><li class="half_rhythm"><div>Hypoplastic nails</div></li><li class="half_rhythm"><div>Hypospadias</div></li><li class="half_rhythm"><div>Hypothyroidism</div></li><li class="half_rhythm"><div>Inguinal hernia</div></li><li class="half_rhythm"><div>Myopi</div></li><li class="half_rhythm"><div>Neonatal hypoglycemia</div></li><li class="half_rhythm"><div>Nystagmus</div></li><li class="half_rhythm"><div>Pectus excavatu</div></li><li class="half_rhythm"><div>Phimosis</div></li><li class="half_rhythm"><div>Skin hyperpigmentation</div></li><li class="half_rhythm"><div>Skin hypopigmentation</div></li><li class="half_rhythm"><div>Strabismus</div></li><li class="half_rhythm"><div>Subpleural blebs</div></li><li class="half_rhythm"><div>Talipes equinovarus</div></li><li class="half_rhythm"><div>Umbilical hernia</div></li><li class="half_rhythm"><div>Vertebral anomalies</div></li><li class="half_rhythm"><div>2/3 toe syndactyly</div></li></ul></div></div><div id="sotos.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Through the evaluation of 234 individuals with Sotos syndrome with an <i>NSD1</i> abnormality, it has been shown that, in general, individuals with a 5q35 microdeletion have less overgrowth and more severe learning disability than individuals with an intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>].</p><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations between intragenic pathogenic variants and 5q35 microdeletions are not evident for other clinical features associated with Sotos syndrome (i.e., cardiac abnormalities, renal anomalies, seizures, scoliosis) &#x02013; nor were correlations observed between type of intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> vs truncating) and phenotype or between position of pathogenic variant (5' vs 3') and phenotype [<a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>].</p></div><div id="sotos.Penetrance"><h3>Penetrance</h3><p><i>NSD1</i> molecular testing is now routinely undertaken in diagnostic genetic laboratories. To date, no unaffected parent or sib with an <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been reported [<a class="bk_pop" href="#sotos.REF.douglas.2003.132">Douglas et al 2003</a>, <a class="bk_pop" href="#sotos.REF.rio.2003.436">Rio et al 2003</a>, <a class="bk_pop" href="#sotos.REF.t_rkmen.2003.858">T&#x000fc;rkmen et al 2003</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>]. Thus, Sotos syndrome appears to be a fully penetrant condition.</p><p>Of note, expressivity is highly variable. Individuals with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, even within the same family, can be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> differently [<a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>, <a class="bk_pop" href="#sotos.REF.donnelly.2011.175">Donnelly et al 2011</a>].</p></div><div id="sotos.Nomenclature"><h3>Nomenclature</h3><p>Sotos syndrome has previously been referred to as cerebral gigantism. This term is now outdated and should no longer be used.</p></div><div id="sotos.Prevalence"><h3>Prevalence</h3><p>Sotos syndrome is estimated to occur in 1:14,000 live births [Authors, unpublished data].</p></div></div><div id="sotos.Genetically_Related_Allelic_Disord"><h2 id="_sotos_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p><i>NSD1</i> abnormalities have a high specificity and <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> for Sotos syndrome. Molecular genetic testing failed to identify pathogenic variants in <i>NSD1</i> in more than 500 individuals with clinical diagnoses other than Sotos syndrome, including Marshall-Smith syndrome, nonspecific overgrowth, and individuals with macrocephaly in association with autism spectrum disorders [<a class="bk_pop" href="#sotos.REF.t_rkmen.2003.858">T&#x000fc;rkmen et al 2003</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>, <a class="bk_pop" href="#sotos.REF.waggoner.2005.524">Waggoner et al 2005</a>, <a class="bk_pop" href="#sotos.REF.buxbaum.2007.68">Buxbaum et al 2007</a>].</p></div><div id="sotos.Differential_Diagnosis"><h2 id="_sotos_Differential_Diagnosis_">Differential Diagnosis</h2><p>Overgrowth conditions that may be confused with Sotos syndrome are summarized in <a class="figpopup" href="/books/NBK1479/table/sotos.T.overgrowth_conditions_to_conside/?report=objectonly" target="object" rid-figpopup="figsotosTovergrowthconditionstoconside" rid-ob="figobsotosTovergrowthconditionstoconside">Table 2</a>.</p><div id="sotos.T.overgrowth_conditions_to_conside" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Overgrowth Conditions to Consider in the Differential Diagnosis of Sotos Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1479/table/sotos.T.overgrowth_conditions_to_conside/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sotos.T.overgrowth_conditions_to_conside_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_1" style="text-align:left;vertical-align:middle;">Differential<br />Diagnosis<br />Disorder</th><th id="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4" id="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/Sotos Syndrome</th><th headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4" id="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from Sotos Syndrome</th></tr></thead><tbody><tr><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/weaver/"><i>EZH2</i>-related Weaver syndrome</a> (Weaver-Smith syndrome)&#x000a0;<sup>1</sup></td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EZH2</i>&#x000a0;<sup>2</sup></td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Typical but subtle facial appearance, esp in early childhood&#x000a0;<sup>3</sup></div></li><li class="half_rhythm"><div>&#x02191; height; macrocephaly; scoliosis; ligamentous laxity</div></li><li class="half_rhythm"><div>Frequently hypotonic at birth (may present w/mixed central hypotonia / peripheral hypertonia)</div></li></ul>
</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Round face shape w/ocular hypertelorism</div></li><li class="half_rhythm"><div>Prognathism is not a feature of Weaver syndrome, but chin appears "stuck on," frequently w/a horizontal crease between chin &#x00026; lower lip.</div></li><li class="half_rhythm"><div>Associated joint problems (e.g., camptodactyly &#x00026; contractures)</div></li><li class="half_rhythm"><div>Infants often have hoarse, low-pitched cry.</div></li></ul>
</td></tr><tr><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cohen-Gibson syndrome&#x000a0;<sup>1,&#x000a0;4</sup><br />(OMIM <a href="https://omim.org/entry/617561" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">617561</a>)</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EED</i></td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Typical but subtle facial appearance, esp in early childhood</div></li><li class="half_rhythm"><div>&#x02191; height; macrocephaly; scoliosis; ligamentous laxity</div></li><li class="half_rhythm"><div>Frequently hypotonic at birth (may present w/mixed central hypotonia / peripheral hypertonia)</div></li></ul>
</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>The face is subtly different, w/hypertelorism, round face, &#x00026; "stuck-on" chin.</div></li><li class="half_rhythm"><div>Other features that do not overlap w/Sotos syndrome are most similar to Weaver syndrome.</div></li></ul>
</td></tr><tr><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SUZ12</i>-overgrowth syndrome&#x000a0;<sup>1,&#x000a0;5</sup></td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SUZ12</i></td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Typical but subtle facial appearance, esp in early childhood</div></li><li class="half_rhythm"><div>&#x02191; height; macrocephaly; scoliosis; ligamentous laxity</div></li><li class="half_rhythm"><div>Frequently hypotonic at birth (may present w/mixed central hypotonia / peripheral hypertonia)</div></li></ul>
</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Features that do not overlap w/Sotos syndrome are most similar to Weaver syndrome.</td></tr><tr><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bws/">Beckwith-Wiedemann syndrome</a> (BWS)</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 6</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequently weight &#x00026;/or height are &#x02265;2 SD at birth.</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>BWS should be clinically distinguishable from Sotos syndrome (molecular testing is indicated in individuals w/clinical overlap).&#x000a0;<sup>7</sup></div></li><li class="half_rhythm"><div>Macroglossia</div></li><li class="half_rhythm"><div>Anterior earlobe creases / helical pits</div></li><li class="half_rhythm"><div>Omphalocele</div></li><li class="half_rhythm"><div>Visceromegaly</div></li><li class="half_rhythm"><div>&#x02191; risk of embryonal tumors, esp Wilms tumor</div></li></ul>
</td></tr><tr><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sgbs/">Simpson-Golabi-Behmel syndrome type 1</a></td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GPC3</i><br /><i>GPC4</i></td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Pre- &#x00026; postnatal overgrowth</div></li><li class="half_rhythm"><div>Variable ID</div></li></ul>
</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Predominantly affects males</div></li><li class="half_rhythm"><div>Polydactyly</div></li><li class="half_rhythm"><div>Supernumerary nipples</div></li><li class="half_rhythm"><div>Diastasis recti</div></li><li class="half_rhythm"><div>Pectus excavatum</div></li><li class="half_rhythm"><div>Facial gestalt differs.&#x000a0;<sup>8</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bannayan-Riley-Ruvalcaba syndrome<br />(see <a href="/books/n/gene/phts/"><i>PTEN</i> Hamartoma Tumor Syndrome</a>)</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PTEN</i></td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>Somewhat similar facial gestalt</div></li><li class="half_rhythm"><div>May be associated w/autistic spectrum disorder</div></li></ul>
</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Vascular malformations</div></li><li class="half_rhythm"><div>Hamartomatous polyps of distal ileum &#x00026; colon</div></li><li class="half_rhythm"><div>Pigmented macules on shaft of penis</div></li><li class="half_rhythm"><div>Lipomas</div></li><li class="half_rhythm"><div>&#x02191; risk of thyroid &#x00026; breast cancer&#x000a0;<sup>8</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fragile X syndrome<br />(see <a href="/books/n/gene/fragilex/"><i>FMR1</i>-Related Disorders</a>)</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FMR1</i></td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Typical but subtle facial appearance may overlap w/Sotos syndrome: dolicocephalic head shape, prominent jaw &#x00026; forehead.</div></li></ul>
</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Predominantly affects males</div></li><li class="half_rhythm"><div>Affected males often have large ears; not common in Sotos syndrome.</div></li><li class="half_rhythm"><div>Macro-orchidism after puberty&#x000a0;<sup>9</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bcns/">Nevoid basal cell carcinoma syndrome</a> (Gorlin syndrome)</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PTCH</i><br /><i>SUFU</i></td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Recognizable appearance w/macrocephaly, bossing of forehead, &#x00026; coarse facial features (in ~60% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals)</div></li><li class="half_rhythm"><div>Head circumference &#x02191; to &#x0003e;98th centile until age 10-18 mos</div></li></ul>
</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Development of multiple jaw keratocysts, frequently beginning in 2nd decade</div></li><li class="half_rhythm"><div>Basal cell carcinomas usually from 3rd decade onward</div></li><li class="half_rhythm"><div>Skeletal anomalies (e.g., bifid ribs or wedge-shaped vertebrae)</div></li><li class="half_rhythm"><div>Absence, usually, of DD&#x000a0;<sup>9</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Malan syndrome&#x000a0;<sup>10</sup><br />(OMIM <a href="https://omim.org/entry/614753" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614753</a>)</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NFIX</i></td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Characteristic facial appearance w/dolicocephaly, prominent forehead, &#x00026; downslanting palpebral fissures</div></li><li class="half_rhythm"><div>Scoliosis; &#x02191; height (&#x0003e;2 SD) in childhood</div></li><li class="half_rhythm"><div>Associated w/variable ID</div></li></ul>
</td><td headers="hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_1_4 hd_h_sotos.T.overgrowth_conditions_to_conside_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ophthalmic abnormalities are common in Malan syndrome; less common in Sotos syndrome.</div></li><li class="half_rhythm"><div>&#x02191; height is less common in older children &#x00026; adults.&#x000a0;<sup>9</sup></div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; DD = developmental delay; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="sotos.TF.2.1"><p class="no_margin">Given the overlap in findings between Sotos syndrome, Weaver syndrome, Cohen-Gibson syndrome, and <i>SUZ12</i>-related overgrowth, in probands with features suggestive of Weaver syndrome, the recommended testing order is <i>NSD1</i>, followed by <i>EZH2</i>, followed by <i>EED</i>, followed by <i>SUZ12</i>.</p></div></dd><dt>2. </dt><dd><div id="sotos.TF.2.2"><p class="no_margin">Weaver syndrome, caused by pathogenic variants in another histone methyl transferase <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, <i>EZH2</i>, is a clinical entity distinct from Sotos syndrome [<a class="bk_pop" href="#sotos.REF.tattonbrown.2011.1127">Tatton-Brown et al 2011</a>, <a class="bk_pop" href="#sotos.REF.gibson.2012.110">Gibson et al 2012</a>].</p></div></dd><dt>3. </dt><dd><div id="sotos.TF.2.3"><p class="no_margin">In some individuals thought to have Weaver syndrome but in whom <i>NSD1</i> pathogenic variants were identified, the clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> evolved to be consistent with Sotos syndrome [<a class="bk_pop" href="#sotos.REF.douglas.2003.132">Douglas et al 2003</a>, <a class="bk_pop" href="#sotos.REF.rio.2003.436">Rio et al 2003</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>].</p></div></dd><dt>4. </dt><dd><div id="sotos.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#sotos.REF.cohen.2015.339">Cohen et al [2015]</a></p></div></dd><dt>5. </dt><dd><div id="sotos.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#sotos.REF.imagawa.2017.637">Imagawa et al [2017]</a></p></div></dd><dt>6. </dt><dd><div id="sotos.TF.2.6"><p class="no_margin">Molecular genetic testing can identify epigenetic and <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> alterations of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 11p15 in individuals with BWS: (1) loss of <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> on the maternal chromosome at <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> center 2 (IC2) in 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; (2) paternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> for chromosome 11p15 in 20%; and (3) gain of methylation on the maternal chromosome at imprinting center 1 (IC1) in 5%. Sequence analysis of <i>CDKN1C</i> identifies pathogenic variants in approximately 40% of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases and 5%-10% of cases with no family history of BWS. Approximately 85% of individuals with BWS have no family history of BWS while approximately 15% have a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> transmission of BWS.</p></div></dd><dt>7. </dt><dd><div id="sotos.TF.2.7"><p class="no_margin"><i>NSD1</i> pathogenic variants were reported in two individuals with BWS; however, the individuals do not fulfill diagnostic criteria for BWS and do fulfill diagnostic criteria for Sotos syndrome [Baujat et al 2004, <a class="bk_pop" href="#sotos.REF.tattonbrown.2004.199">Tatton-Brown &#x00026; Rahman 2004</a>].</p></div></dd><dt>8. </dt><dd><div id="sotos.TF.2.8"><p class="no_margin">Detailed clinical examination &#x00026; <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> should differentiate the disorder from Sotos syndrome.</p></div></dd><dt>9. </dt><dd><div id="sotos.TF.2.9"><p class="no_margin">Usually distinguishable from Sotos syndrome on clinical grounds; molecular testing confirms the diagnosis.</p></div></dd><dt>10. </dt><dd><div id="sotos.TF.2.10"><p class="no_margin"><a class="bk_pop" href="#sotos.REF.priolo.2018.1226">Priolo et al [2018]</a></p></div></dd></dl></div></div></div><p>Other conditions to consider in the differential diagnosis of Sotos syndrome include the following:</p><ul><li class="half_rhythm"><div><b>Chromosome abnormalities.</b> A Sotos syndrome-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has been associated with 4p duplications, mosaic 20p trisomy [<a class="bk_pop" href="#sotos.REF.faivre.2000.273">Faivre et al 2000</a>], and <a href="/books/n/gene/gr_22q13_3/">22q13.3 deletion syndrome</a>.</div></li><li class="half_rhythm"><div><b>Nonspecific overgrowth.</b> Many individuals with overgrowth do not fulfill the diagnostic criteria for any of the above conditions but nevertheless have other features (e.g., learning difficulties, distinctive facial features) that suggest an underlying genetic cause. Nonspecific overgrowth is likely to be a heterogeneous group of conditions with multiple causes.</div></li></ul></div><div id="sotos.Management"><h2 id="_sotos_Management_">Management</h2><div id="sotos.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Sotos syndrome, the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended [<a class="bk_pop" href="#sotos.REF.tattonbrown.2007.264">Tatton-Brown &#x00026; Rahman 2007</a>]:</p><ul><li class="half_rhythm"><div>A thorough history to identify known features of Sotos syndrome: learning difficulties, cardiac and renal anomalies, seizures, and scoliosis</div></li><li class="half_rhythm"><div>Physical examination including cardiac auscultation, blood pressure measurement, and back examination for scoliosis</div></li><li class="half_rhythm"><div>Investigations to detect abnormalities before they result in significant morbidity or mortality:</div><ul><li class="half_rhythm"><div>In children in whom the diagnosis has just been established, echocardiogram and renal ultrasound examination</div></li><li class="half_rhythm"><div>In adults in whom the diagnosis has just been established, renal ultrasound examination to evaluate for renal damage from quiescent chronic vesicoureteral reflux</div></li><li class="half_rhythm"><div>Referral for audiologic assessment. Conductive hearing loss may occur at an increased frequency in Sotos syndrome; thus, the threshold for referral should be low.</div></li></ul></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="sotos.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>When clinical problems (e.g., cardiac anomalies, renal anomalies, scoliosis, or seizures) are identified, referral to the appropriate specialist is recommended.</p><p>If brain MRI has been performed and ventricular dilatation demonstrated, shunting should not usually be necessary as the "arrested hydrocephalus" associated with Sotos syndrome is typically not obstructive and not associated with raised intracranial pressure. If raised intracranial pressure is suspected, investigation and management in consultation with neurologists and neurosurgeons would be appropriate.</p><div id="sotos.Developmental_Delay__Intellectual"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>For difficulties with learning/behavior/speech that can be found in individuals with Sotos syndrome, the following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="sotos.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., contractures, scoliosis, hip dislocation).</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li><li class="half_rhythm"><div>For muscle tone abnormalities including hypertonia or dystonia, consider involving appropriate specialists to aid in management of baclofen, Botox<sup>&#x000ae;</sup>, anti-parkinsonian medications, or orthopedic procedures.</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div><div id="sotos.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavioral management strategies or providing prescription medications when necessary.</p><p>Concerns about serious aggressive or destructive behavior can be addressed by a pediatric psychiatrist.</p></div></div><div id="sotos.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Antibiotic prophylaxis is indicated in individuals with vesicoureteral reflux.</p></div><div id="sotos.Surveillance"><h3>Surveillance</h3><p>Regular evaluation by a general pediatrician is recommended for younger children, individuals with many medical complications needing coordination of medical specialists, and families requiring more support than average [<a class="bk_pop" href="#sotos.REF.tattonbrown.2007.264">Tatton-Brown &#x00026; Rahman 2007</a>].</p><p>The clinician may wish to evaluate older children, teenagers, and those individuals without many medical complications less frequently.</p><div id="sotos.T.recommended_surveillance_for_ind" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Sotos Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1479/table/sotos.T.recommended_surveillance_for_ind/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sotos.T.recommended_surveillance_for_ind_lrgtbl__"><table><thead><tr><th id="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation by cardiologist</td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At clinical review</td></tr><tr><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Echocardiogram</td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Baseline echocardiogram at diagnosis</div></li><li class="half_rhythm"><div>Need for &#x00026; timing of follow-up studies determined by cardiologist</div></li></ul>
</td></tr><tr><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Blood pressure check</td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At clinical review</td></tr><tr><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal</b></td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Examine spine for curvature.</td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At clinical review</td></tr><tr><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Urinary tract</b></td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Urinalysis, urine culture for quiescent urine infection</td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At clinical review</td></tr><tr><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic exam</td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Where there are concerns</td></tr><tr><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ears</b></td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing test</td><td headers="hd_h_sotos.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Where there are concerns</td></tr></tbody></table></div></div><p>Note: Cancer screening is not recommended [<a class="bk_pop" href="#sotos.REF.villani.2017.e83">Villani et al 2017</a>]:</p><ul><li class="half_rhythm"><div>The absolute risk of sacrococcygeal teratoma and neuroblastoma is low (~1%) [<a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2007.264">Tatton-Brown &#x00026; Rahman 2007</a>, <a class="bk_pop" href="#sotos.REF.foster.2019">Foster et al 2019</a>]. This level of risk does not warrant routine screening, particularly as screening for neuroblastoma has not been shown to decrease mortality and can lead to false positive results [<a class="bk_pop" href="#sotos.REF.schilling.2002.1047">Schilling et al 2002</a>].</div></li><li class="half_rhythm"><div>Wilms tumor risk is not significantly increased and routine renal ultrasound examination is not indicated [<a class="bk_pop" href="#sotos.REF.scott.2006.995">Scott et al 2006</a>].</div></li></ul></div><div id="sotos.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#sotos.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="sotos.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="sotos.Genetic_Counseling"><h2 id="_sotos_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sotos.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Sotos syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="sotos.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>About 5% of individuals diagnosed with Sotos syndrome have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>The remaining approximately 95% of individuals have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If a parent of an individual with an identified <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> does not have any clinical features of Sotos syndrome, that parent is very unlikely to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a pathogenic variant in <i>NSD1</i>. This can be confirmed with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the parent for the <i>NSD1</i> pathogenic variant identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the pathogenic variant is most likely <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the proband. Another possible explanation is <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent; germline mosaicism is rare with only one recent report of somatic and germline mosaicism in the unaffected father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual [<a class="bk_pop" href="#sotos.REF.kamien.2016.3360">Kamien et al 2016</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of a proband depends on the clinical/genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has an <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the pathogenic variant is 50%. Intrafamilial clinical variability has been reported [<a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. However, sibs of a proband with clinically unaffected parents are still presumed to be at increased risk for Sotos syndrome because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#sotos.REF.kamien.2016.3360">Kamien et al 2016</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with Sotos syndrome has a 50% chance of inheriting the <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Phenotypic expression can vary from one generation to the next and thus it is not possible to accurately predict how offspring may be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="sotos.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with Sotos syndrome has the <i>NSD1</i> pathogenic variant or clinical evidence of the disorder, it is extremely likely that the proband has a <i>de novo</i> pathogenic variant. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sotos.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>NSD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk for Sotos syndrome and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible. Note that phenotypic expression can vary from one generation to the next; thus, it is not possible to accurately predict <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> on the basis of prenatal molecular genetic test results.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p><p><b>Ultrasound examination.</b> Prenatal diagnosis cannot be accurately accomplished by ultrasound examination: the features of Sotos syndrome likely to be detected by ultrasound examination, such as macrocephaly and increased length, are nonspecific.</p></div></div><div id="sotos.Resources"><h2 id="_sotos_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Sotos%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sotos Syndrome</a></div></li><li class="half_rhythm"><div><b>Sotos Syndrome Support Association (SSSA)</b></div><div>PO Box 4626</div><div>Wheaton IL 60189</div><div><b>Phone:</b> 888-246-7772 (toll-free)</div><div><b>Email:</b> info@sotosyndrome.org</div><div><a href="http://www.sotossyndrome.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.sotossyndrome.org</a></div></li><li class="half_rhythm"><div><b>Child Growth Foundation</b></div><div>21 Malvern Drive</div><div>West Midlands B76 1PZ</div><div>United Kingdom</div><div><b>Phone:</b> 020 8995 0257</div><div><b>Email:</b> nfo@childgrowthfoundation.org</div><div><a href="http://www.childgrowthfoundation.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.childgrowthfoundation.org</a></div></li></ul></div><div id="sotos.Molecular_Genetics"><h2 id="_sotos_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sotos.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Sotos Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1479/table/sotos.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sotos.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sotos.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sotos.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sotos.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sotos.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_sotos.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sotos.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sotos.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/64324" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>NSD1</i></a></td><td headers="hd_b_sotos.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=64324" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q35<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_sotos.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96L73" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific</a></td><td headers="hd_b_sotos.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.lovd.nl/NSD1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Nuclear receptor binding SET Domain protein 1 (NSD1) @ LOVD</a></td><td headers="hd_b_sotos.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=NSD1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NSD1</a></td><td headers="hd_b_sotos.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NSD1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NSD1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sotos.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sotos.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Sotos Syndrome (<a href="/omim/117550,606681" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1479/table/sotos.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sotos.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/117550" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">117550</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOTOS SYNDROME 1; SOTOS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606681" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606681</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NUCLEAR RECEPTOR-BINDING SET DOMAIN PROTEIN 1; NSD1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>NSD1</i> comprises 22 coding exons (<a href="/nuccore/NM_022455.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_022455.4</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1479/#sotos.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 100 pathogenic variants have been reported. No mutational hot spots have been identified [<a class="bk_pop" href="#sotos.REF.douglas.2003.132">Douglas et al 2003</a>, <a class="bk_pop" href="#sotos.REF.kurotaki.2003.378">Kurotaki et al 2003</a>, <a class="bk_pop" href="#sotos.REF.rio.2003.436">Rio et al 2003</a>, <a class="bk_pop" href="#sotos.REF.t_rkmen.2003.858">T&#x000fc;rkmen et al 2003</a>, <a class="bk_pop" href="#sotos.REF.faravelli.2005.24">Faravelli 2005</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>]. See <a href="/books/NBK1479/#sotos.molgen.TA">Table A</a>.</p><p>A recurrent 1.9-Mb 5q35 microdeletion encompassing <i>NSD1</i> has been reported in most Japanese and some non-Japanese individuals with Sotos syndrome [<a class="bk_pop" href="#sotos.REF.kurotaki.2003.378">Kurotaki et al 2003</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2005a.307">Tatton-Brown et al 2005a</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2005b.193">Tatton-Brown et al 2005b</a>, <a class="bk_pop" href="#sotos.REF.visser.2005.e66">Visser et al 2005</a>]. Further data about population distribution of this microdeletion are not yet available. The majority of microdeletions are generated by <a class="def" href="/books/n/gene/glossary/def-item/nonallelic-homologous-recombination/">nonallelic homologous recombination</a> between flanking low-copy repeats [<a class="bk_pop" href="#sotos.REF.kurotaki.2003.378">Kurotaki et al 2003</a>, <a class="bk_pop" href="#sotos.REF.tattonbrown.2005a.307">Tatton-Brown et al 2005a</a>, <a class="bk_pop" href="#sotos.REF.visser.2005.e66">Visser et al 2005</a>]. Many of these recurrent deletions have the same breakpoints, and a specific chromatin structure may increase recurrent crossover events and predispose to recombination hot spots at 5q35 [<a class="bk_pop" href="#sotos.REF.visser.2005.e66">Visser et al 2005</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Only limited data exist regarding the functions of the 2,696-amino acid protein encoded by <i>NSD1</i>: histone-lysine N-methyltransferase, H3 lysine-36, and H4 lysine-20 specific. It is expressed in the brain, kidney, skeletal muscle, spleen, thymus, and lung.</p><p>NSD1 contains at least 12 functional domains:</p><ul><li class="half_rhythm"><div>Two nuclear receptor interaction domains (NID<sup>-L</sup> and NID<sup>+L</sup>)</div></li><li class="half_rhythm"><div>Two proline-tryptophan-tryptophan-proline (PWWP) domains</div></li><li class="half_rhythm"><div>Five plant homeo domains (PHD)</div></li><li class="half_rhythm"><div>A SET (su(var)3-9, enhancer of zeste, trithorax) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a></div></li></ul><p>The most distinctive of these domains are the SET and associated SAC (SET-associated Cys-rich) domains, which are found in histone methyltransferases that regulate chromatin states. The SET <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of NSD1 has unique histone specificity, methylating lysine residue 36 on histone H3, and lysine residue 20 on histone H4 (K36H3 and K20H4) [<a class="bk_pop" href="#sotos.REF.rayasam.2003.3153">Rayasam et al 2003</a>]. PHDs are also typically found in proteins that act at the chromatin level, and PWWP domains are implicated in protein-protein interactions and are often found in methyltransferases.</p><p>The nuclear receptors of NSD1, NID<sup>-L</sup>, and NID<sup>+L</sup> are typical of those found in corepressors and coactivators [<a class="bk_pop" href="#sotos.REF.huang.1998.3398">Huang et al 1998</a>]. The presence of these distinctive domains suggests that NSD1 is a histone methyltransferase that acts as a transcriptional intermediary factor capable of both negatively and positively influencing transcription, depending on the cellular context [<a class="bk_pop" href="#sotos.REF.kurotaki.2001.197">Kurotaki et al 2001</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Sotos syndrome results from loss of NSD1 function. How functional abrogation of NSD1 results in Sotos syndrome is not currently known.</p></div><div id="sotos.References"><h2 id="_sotos_References_">References</h2><div id="sotos.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.agwu.1999.339">Agwu JC, Shaw NJ, Kirk J, Chapman S, Ravine D, Cole TR. Growth in Sotos syndrome. <span><span class="ref-journal">Arch Dis Child. </span>1999;<span class="ref-vol">80</span>:339–42.</span> [<a href="/pmc/articles/PMC1717905/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1717905</span></a>] [<a href="/pubmed/10086939" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10086939</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.allanson.1996.13">Allanson JE, Cole TR. Sotos syndrome: evolution of facial phenotype subjective and objective assessment. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">65</span>:13–20.</span> [<a href="/pubmed/8914735" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8914735</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.baujat.2004.715">Baujat G, Rio M, Rossignol S, Sanlaville D, Lyonnet S, Le Merrer M, Munnich A, Gicquel C, Cormier-Daire V, Colleaux L. Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">74</span>:715–20.</span> [<a href="/pmc/articles/PMC1181947/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1181947</span></a>] [<a href="/pubmed/14997421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14997421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.buxbaum.2007.68">Buxbaum JD, Cai G, Nygren G, Chaste P, Delorme R, Goldsmith J, R&#x000e5;stam M, Silverman JM, Hollander E, Gillberg C, Leboyer M, Betancur C. Mutation analysis of the NSD1 gene in patients with autism spectrum disorders and macrocephaly. <span><span class="ref-journal">BMC Med Genet. </span>2007;<span class="ref-vol">8</span>:68.</span> [<a href="/pmc/articles/PMC2248565/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2248565</span></a>] [<a href="/pubmed/18001468" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18001468</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.cohen.2015.339">Cohen AS, Tuysuz B, Shen Y, Bhalla SK, Jones SJ, Gibson WT. A novel mutation in EED associated with overgrowth. <span><span class="ref-journal">J Hum Genet. </span>2015;<span class="ref-vol">60</span>:339–42.</span> [<a href="/pubmed/25787343" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25787343</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.cole.1994.20">Cole TR, Hughes HE. Sotos syndrome: a study of the diagnostic criteria and natural history. <span><span class="ref-journal">J Med Genet. </span>1994;<span class="ref-vol">31</span>:20–32.</span> [<a href="/pmc/articles/PMC1049594/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1049594</span></a>] [<a href="/pubmed/7512144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7512144</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.de_boer.2005.1142">de Boer L, le Cessie S, Wit JM. Auxological data in patients clinically suspected of Sotos syndrome with NSD1 gene alterations. <span><span class="ref-journal">Acta Paediatr. </span>2005;<span class="ref-vol">94</span>:1142–4.</span> [<a href="/pubmed/16188863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16188863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.de_boer.2006.582">de Boer L, Roder I, Wit JM. Psychosocial, cognitive, and motor functioning in patients with suspected Sotos syndrome: a comparison between patients with and without NSD1 gene alterations. <span><span class="ref-journal">Dev Med Child Neurol. </span>2006;<span class="ref-vol">48</span>:582–8.</span> [<a href="/pubmed/16780628" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16780628</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.donnelly.2011.175">Donnelly DE, Turnpenny P, McConnell VP. Phenotypic variability in a three-generation Northern Irish family with Sotos syndrome. <span><span class="ref-journal">Clin Dysmorphol. </span>2011;<span class="ref-vol">20</span>:175–81.</span> [<a href="/pubmed/21738022" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21738022</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.douglas.2003.132">Douglas J, Hanks S, Temple IK, Davies S, Murray A, Upadhyaya M, Tomkins S, Hughes HE, Cole TR, Rahman N. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:132–43.</span> [<a href="/pmc/articles/PMC378618/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC378618</span></a>] [<a href="/pubmed/12464997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12464997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.faivre.2000.273">Faivre L, Viot G, Prieur M, Turleau C, Gosset P, Romana S, Munnich A, Vekemans M, Cormier-Daire V. Apparent Sotos syndrome (cerebral gigantism) in a child with trisomy 20p11.2-p12.1 mosaicism. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">91</span>:273–6.</span> [<a href="/pubmed/10766982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10766982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.faravelli.2005.24">Faravelli F. NSD1 mutations in Sotos syndrome. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2005;<span class="ref-vol">137C</span>:24–31.</span> [<a href="/pubmed/16010675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16010675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.finegan.1994.1307">Finegan JK, Cole TR, Kingwell E, Smith ML, Smith M, Sitarenios G. Language and behavior in children with Sotos syndrome. <span><span class="ref-journal">J Am Acad Child Adolesc Psychiatry. </span>1994;<span class="ref-vol">33</span>:1307–15.</span> [<a href="/pubmed/7995798" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7995798</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.foster.2019">Foster A, Zachariou A, Loveday C, Ashraf T, Blair E, Clayton-Smith J, Dorkins H, Fryer A, Gener B, Goudie D, Henderson A, Irving M, Joss S, Keeley V, Lahiri N, Lynch SA, Mansour S, McCann E, Morton J, Motton N, Murray A, Riches K, Shears D, Stark Z, Thompson E, Vogt J, Wright M, Cole T, Tatton-Brown K. The phenotype of Sotos syndrome in adulthood: a review of 44 individuals. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2019.</span> Epub ahead of print. [<a href="/pubmed/31479583" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31479583</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.gibson.2012.110">Gibson WT, Hood RL, Zhan SH, Bulman DE, Fejes AP, Moore R, Mungall AJ, Eydoux P, Babul-Hirji R, An J, Marra MA, Chitayat D, Boycott KM, Weaver DD, Jones SJ, et al.  Mutations in EZH2 cause Weaver syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:110–8.</span> [<a href="/pmc/articles/PMC3257956/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3257956</span></a>] [<a href="/pubmed/22177091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22177091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.hersh.1992.572">Hersh JH, Cole TR, Bloom AS, Bertolone SJ, Hughes HE. Risk of malignancy in Sotos syndrome. <span><span class="ref-journal">J Pediatr. </span>1992;<span class="ref-vol">120</span>:572–4.</span> [<a href="/pubmed/1552397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1552397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.hood.2016.531">Hood RL, McGillivray G, Hunter MF, Roberston SP, Bulman DE, Boycott KM, Stark Z, et al.  Severe connective tissue laxity including aortic dilatation in Sotos syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170A</span>:531–5.</span> [<a href="/pubmed/26613968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26613968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.huang.1998.3398">Huang N, vom Baur E, Garnier JM, Lerouge T, Vonesch JL, Lutz Y, Chambon P, Losson R. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators. <span><span class="ref-journal">EMBO J. </span>1998;<span class="ref-vol">17</span>:3398–412.</span> [<a href="/pmc/articles/PMC1170677/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1170677</span></a>] [<a href="/pubmed/9628876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9628876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.imagawa.2017.637">Imagawa E, Higashimoto K, Sakai Y, Numakura C, Okamoto N, Matsunaga S, Ryo A, Sato Y, Sanefuji M, Ihara K, Takada Y, Nishimura G, Saitsu H, Mizuguchi T, Miyatake S, Nakashima M, Miyake N, Soejima H, Matsumoto N. Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome. <span><span class="ref-journal">Hum Mutat. </span>2017;<span class="ref-vol">38</span>:637–48.</span> [<a href="/pubmed/28229514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28229514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.kamien.2016.3360">Kamien B, Dadd T, Buckman M, Ronan A, Dudding T, Meldrum C, Scott R, Mina K. Somatic-gonadal mosaicism causing Sotos syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170</span>:3360–2.</span> [<a href="/pubmed/27604501" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27604501</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.kurotaki.2003.378">Kurotaki N, Harada N, Shimokawa O, Miyake N, Kawame H, Uetake K, Makita Y, Kondoh T, Ogata T, Hasegawa T, Nagai T, Ozaki T, Touyama M, Shenhav R, Ohashi H, Medne L, Shiihara T, Ohtsu S, Kato Z, Okamoto N, Nishimoto J, Lev D, Miyoshi Y, Ishikiriyama S, Sonoda T, Sakazume S, Fukushima Y, Kurosawa K, Cheng JF, Yoshiura K, Ohta T, Kishino T, Niikawa N, Matsumoto N. Fifty microdeletions among 112 cases of Sotos syndrome: low copy repeats possibly mediate the common deletion. <span><span class="ref-journal">Hum Mutat. </span>2003;<span class="ref-vol">22</span>:378–87.</span> [<a href="/pubmed/14517949" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14517949</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.kurotaki.2001.197">Kurotaki N, Harada N, Yoshiura K, Sugano S, Niikawa N, Matsumoto N. Molecular characterization of NSD1, a human homologue of the mouse Nsd1 gene. <span><span class="ref-journal">Gene. </span>2001;<span class="ref-vol">279</span>:197–204.</span> [<a href="/pubmed/11733144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11733144</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.lane.2017.135">Lane C, Milne E, Freeth M. Characteristics of autism spectrum disorder in Sotos syndrome. <span><span class="ref-journal">J Autism Dev Disord. </span>2017;<span class="ref-vol">47</span>:135–43.</span> [<a href="/pmc/articles/PMC5222916/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5222916</span></a>] [<a href="/pubmed/27771801" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27771801</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.lane.2019.240">Lane C, Milne E, Freeth M. The cognitive profile of Sotos syndrome. <span><span class="ref-journal">J Neuropsychol. </span>2019;<span class="ref-vol">13</span>:240–52.</span> [<a href="/pubmed/29336120" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29336120</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.martinez.2011.1115">Martinez HR, Belmont JW, Craigen WJ, Taylor MD, Jefferies JL. Left ventricular noncompaction in Sotos syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:1115–8.</span> [<a href="/pubmed/21484993" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21484993</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.priolo.2018.1226">Priolo M, Schanze D, Tatton-Brown K, Mulder PA, Tenorio J, Kooblall K, Acero IH, Alkuraya FS, Arias P, Bernardini L, Bijlsma EK, Cole T, Coubes C, Dapia I, Davies S, Di Donato N, Elcioglu NH, Fahrner JA, Foster A, Gonz&#x000e1;lez NG, Huber I, Iascone M, Kaiser AS, Kamath A, Liebelt J, Lynch SA, Maas SM, Mamm&#x000ec; C, Mathijssen IB, McKee S, Menke LA, Mirzaa GM, Montgomery T, Neubauer D, Neumann TE, Pintomalli L, Pisanti MA, Plomp AS, Price S, Salter C, Santos-Simarro F, Sarda P, Segovia M, Shaw-Smith C, Smithson S, Suri M, Valdez RM, Van Haeringen A, Van Hagen JM, Zollino M, Lapunzina P, Thakker RV, Zenker M, Hennekam RC. Further delineation of Malan syndrome. <span><span class="ref-journal">Hum Mutat. </span>2018;<span class="ref-vol">39</span>:1226–37.</span> [<a href="/pmc/articles/PMC6175110/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6175110</span></a>] [<a href="/pubmed/29897170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29897170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.rayasam.2003.3153">Rayasam GV, Wendling O, Angrand PO, Mark M, Niederreither K, Song L, Lerouge T, Hager GL, Chambon P, Losson R. NSD1 is essential for early post-implantation development and has a catalytically active SET domain. <span><span class="ref-journal">EMBO J. </span>2003;<span class="ref-vol">22</span>:3153–63.</span> [<a href="/pmc/articles/PMC162140/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC162140</span></a>] [<a href="/pubmed/12805229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12805229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.rio.2003.436">Rio M, Clech L, Amiel J, Faivre L, Lyonnet S, Le Merrer M, Odent S, Lacombe D, Edery P, Brauner R, Raoul O, Gosset P, Prieur M, Vekemans M, Munnich A, Colleaux L, Cormier-Daire V. Spectrum of NSD1 mutations in Sotos and Weaver syndromes. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:436–40.</span> [<a href="/pmc/articles/PMC1735492/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735492</span></a>] [<a href="/pubmed/12807965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12807965</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.schilling.2002.1047">Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J. Neuroblastoma screening at one year of age. <span><span class="ref-journal">N Engl J Med. </span>2002;<span class="ref-vol">346</span>:1047–53.</span> [<a href="/pubmed/11932471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11932471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.scott.2006.995">Scott RH, Walker L, Olsen &#x000d8;E, Levitt G, Kenney I, Maher E, Owens CM, Pritchard-Jones K, Craft A, Rahman N. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. <span><span class="ref-journal">Arch Dis Child. </span>2006;<span class="ref-vol">91</span>:995–9.</span> [<a href="/pmc/articles/PMC2083016/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2083016</span></a>] [<a href="/pubmed/16857697" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16857697</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.sheth.2015.2945">Sheth K, Moss J, Hyland S, Stinton C, Cole T, Oliver C. The behavioral characteristics of Sotos syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:2945–56.</span> [<a href="/pubmed/26418839" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26418839</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.tattonbrown.2005a.307">Tatton-Brown K, Douglas J, Coleman K, Baujat G, Chandler K, Clarke A, Collins A, Davies S, Faravelli F, Firth H, Garrett C, Hughes H, Kerr B, Liebelt J, Reardon W, Schaefer GB, Splitt M, Temple IK, Waggoner D, Weaver DD, Wilson L, Cole T, Cormier-Daire V, Irrthum A, Rahman N. Multiple mechanisms are implicated in the generation of 5q35 microdeletions in Sotos syndrome. <span><span class="ref-journal">J Med Genet. </span>2005a;<span class="ref-vol">42</span>:307–13.</span> [<a href="/pmc/articles/PMC1736029/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736029</span></a>] [<a href="/pubmed/15805156" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15805156</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.tattonbrown.2005b.193">Tatton-Brown K, Douglas J, Coleman K, Baujat G, Cole TR, Das S, Horn D, Hughes HE, Temple IK, Faravelli F, Waggoner D, Turkmen S, Cormier-Daire V, Irrthum A, Rahman N. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. <span><span class="ref-journal">Am J Hum Genet. </span>2005b;<span class="ref-vol">77</span>:193–204.</span> [<a href="/pmc/articles/PMC1224542/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1224542</span></a>] [<a href="/pubmed/15942875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15942875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.tattonbrown.2011.1127">Tatton-Brown K, Hanks S, Ruark E, Zachariou A, Duarte Sdel V, Ramsay E, Snape K, Murray A, Perdeaux ER, Seal S, Loveday C, Banka S, Clericuzio C, Flinter F, Magee A, McConnell V, Patton M, Raith W, Rankin J, Splitt M, Strenger V, Taylor C, Wheeler P, Temple KI, Cole T, Douglas J, Rahman N, et al.  Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height. <span><span class="ref-journal">Oncotarget. </span>2011;<span class="ref-vol">2</span>:1127–33.</span> [<a href="/pmc/articles/PMC3282071/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3282071</span></a>] [<a href="/pubmed/22190405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22190405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.tattonbrown.2004.199">Tatton-Brown K, Rahman N. Clinical features of NSD1-positive Sotos syndrome. <span><span class="ref-journal">Clin Dysmorphol. </span>2004;<span class="ref-vol">13</span>:199–204.</span> [<a href="/pubmed/15365454" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15365454</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.tattonbrown.2007.264">Tatton-Brown K, Rahman N. Sotos syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2007;<span class="ref-vol">15</span>:264–71.</span> [<a href="/pubmed/16969376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16969376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.theodoulou.2015.413">Theodoulou E, Baborie A, Jenkinson MD. Low grade glioma in an adult patient with Sotos syndrome. <span><span class="ref-journal">J Clin Neurosci. </span>2015;<span class="ref-vol">22</span>:413–5.</span> [<a href="/pubmed/25304431" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25304431</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.t_rkmen.2003.858">T&#x000fc;rkmen S, Gillessen-Kaesbach G, Meinecke P, Albrecht B, Neumann LM, Hesse V, Palanduz S, Balg S, Majewski F, Fuchs S, Zschieschang P, Greiwe M, Mennicke K, Kreuz FR, Dehmel HJ, Rodeck B, Kunze J, Tinschert S, Mundlos S, Horn D. Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes. <span><span class="ref-journal">Eur J Hum Genet. </span>2003;<span class="ref-vol">11</span>:858–65.</span> [<a href="/pubmed/14571271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14571271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.villani.2017.e83">Villani A, Greer MC, Kalish JM, Nakagawara A, Nathanson KL, Pajtler KW, Pfister SM, Walsh MF, Wasserman JD, Zelley K, Kratz CP. Recommendations for cancer surveillance in individuals with RASopathies and other rare genetic conditions with increased cancer risk. <span><span class="ref-journal">Clin Cancer Res. </span>2017;<span class="ref-vol">23</span>:e83–e90.</span> [<a href="/pubmed/28620009" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28620009</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.visser.2005.e66">Visser R, Shimokawa O, Harada N, Niikawa N, Matsumoto N. Non-hotspot-related breakpoints of common deletions in Sotos syndrome are located within destabilised DNA regions. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:e66.</span> [<a href="/pmc/articles/PMC1735942/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735942</span></a>] [<a href="/pubmed/16272258" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16272258</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sotos.REF.waggoner.2005.524">Waggoner DJ, Raca G, Welch K, Dempsey M, Anderes E, Ostrovnaya I, Alkhateeb A, Kamimura J, Matsumoto N, Schaeffer GB, Martin CL, Das S. NSD1 analysis for Sotos syndrome: insights and perspectives from the clinical laboratory. <span><span class="ref-journal">Genet Med. </span>2005;<span class="ref-vol">7</span>:524–33.</span> [<a href="/pubmed/16247291" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16247291</span></a>]</div></li></ul></div></div><div id="sotos.Chapter_Notes"><h2 id="_sotos_Chapter_Notes_">Chapter Notes</h2><div id="sotos.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>1 August 2019 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 November 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 March 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 December 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 March 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>17 December 2004 (me) Review posted live</div></li><li class="half_rhythm"><div>26 May 2004 (tc) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1479</span><span class="label">PMID: <a href="/pubmed/20301652" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301652</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/snyder-robinson/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/spg3a/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1479&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1479/?report=reader">PubReader</a></li><li><a href="/books/NBK1479/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1479" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1479" style="display:none" title="Cite this Page"><div class="bk_tt">Tatton-Brown K, Cole TRP, Rahman N. Sotos Syndrome. 2004 Dec 17 [Updated 2019 Aug 1]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1479/pdf/Bookshelf_NBK1479.pdf">PDF version of this page</a> (487K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sotos.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sotos.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sotos.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sotos.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sotos.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sotos.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sotos.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sotos.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sotos.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sotos.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sotos.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=64324[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NSD1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1466902" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1466902" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1466902" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1466902" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23865096" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EZH2</i>-Related Overgrowth</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EZH2</i>-Related Overgrowth<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tatton-Brown K, Rahman N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21882399" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Kabuki Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Kabuki Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Adam MP, Hudgins L, Hannibal M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31479583" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The phenotype of Sotos syndrome in adulthood: A review of 44 individuals.</a><span class="source">[Am J Med Genet C Semin Med Gen...]</span><div class="brieflinkpop offscreen_noflow">The phenotype of Sotos syndrome in adulthood: A review of 44 individuals.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Foster A, Zachariou A, Loveday C, Ashraf T, Blair E, Clayton-Smith J, Dorkins H, Fryer A, Gener B, Goudie D, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet C Semin Med Genet. 2019 Dec; 181(4):502-508. Epub 2019 Sep 3.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301699" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Rubinstein-Taybi Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Rubinstein-Taybi Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stevens CA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301652" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301652" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d48dd21425a255865a5">Sotos Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Sotos Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:30:48-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A40B7E04091C10000000001A6009B&amp;ncbi_session=CE8A40B7E040D481_0422SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1479%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1479&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1479/&amp;ncbi_pagename=Sotos Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A40B7E040D481_0422SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>